The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024
Write the words of this act the way you think they should read. Solon shows your change as a redline against the published text and pins it to that exact text, so it can never be applied to wording you did not see.
Change 1
8 Exception for private prescriptions: patients aged under 18 – treatment for the purposes of puberty suppression in respect of gender dysphoria etc.
(1) Article 4 does not apply to a sale or supply in pursuance of a private prescription, if the purpose for which the private prescription was issued is treatment for the purpose of puberty suppression in respect of gender dysphoria, gender incongruence or a combination of both, where— (a) Condition A is met; (b) if the prescription is a standard private prescription, Condition B is met; and (c) if the prescription was issued— (i) in England and Wales and Scotland, on or after 3rd June 2024, or (ii) in Northern Ireland, on or after 27th August 2024, Condition C and condition D are met. (2) Condition A is that on the day the prescription was issued, the patient in respect of whom it was issued was aged under 18. (3) Condition B is that— (a) the prescription has included within it the patient’s age and is annotated by the prescriber with “SLS”; or (b) in— (i) England and Wales and Scotland, if the prescription was issued before 3rd June 2024, or (ii) Northern Ireland, if the prescription was issued before 27th August 2024, the person to whom the GnRH analogue is to be sold or supplied produces to the person selling or supplying the GnRH analogue a specified document, a UK birth certificate or a current national identity document that verifies, to the reasonable satisfaction of the person selling or supplying the GnRH analogue, the age and identity of the person to or for whom the GnRH analogue is to be sold or supplied. (4) Condition C is that the prescription was issued by an approved UK prescriber. (5) Condition D is that the sale or supply is to or for a person who, on any occasion, started a course of treatment with a GnRH analogue— (a) in England and Wales and Scotland, before 3rd June 2024; or (b) in Northern Ireland, before 27th August 2024. (6) For the purposes of paragraph (5), a person is treated as having started a course of treatment with a GnRH analogue if— (a) in England and Wales and Scotland, in the six month period before 3rd June 2024, that person was issued with a NHS prescription or a private prescription for a GnRH analogue, whether or not the prescription has been dispensed or the prescribed GnRH analogue has been taken by that person before 3rd June 2024 or since; or (b) in Northern Ireland, in the six month period before 27th August 2024, that person was issued with a NHS prescription or a private prescription for a GnRH analogue, whether or not the prescription has been dispensed or the prescribed GnRH analogue has been taken by that person before 27th August 2024 or since.
8 Exception for private prescriptions: patients aged under 18 – treatment for the purposes of puberty suppression in respect of gender dysphoria etc.
(1) Article 4 does not apply to a sale or supply in pursuance of a private prescription, if the purpose for which the private prescription was issued is treatment for the purpose of puberty suppression in respect of gender dysphoria, gender incongruence or a combination of both, where— (a) Condition A is met; (b) if the prescription is a standard private prescription, Condition B is met; and (c) if the prescription was issued— (i) in England and Wales and Scotland, on or after 3rd June 2024, or (ii) in Northern Ireland, on or after 27th August 2024, Condition C and condition D are met. (2) Condition A is that on the day the prescription was issued, the patient in respect of whom it was issued was aged under 18. (3) Condition B is that— (a) the prescription has included within it the patient’s age and is annotated by the prescriber with “SLS”; or (b) in— (i) England and Wales and Scotland, if the prescription was issued before 3rd June 2024, or (ii) Northern Ireland, if the prescription was issued before 27th August 2024, the person to whom the GnRH analogue is to be sold or supplied produces to the person selling or supplying the GnRH analogue a specified document, a UK birth certificate or a current national identity document that verifies, to the reasonable satisfaction of the person selling or supplying the GnRH analogue, the age and identity of the person to or for whom the GnRH analogue is to be sold or supplied. (4) Condition C is that the prescription was issued by an approved UK prescriber. (5) Condition D is that the sale or supply is to or for a person who, on any occasion, started a course of treatment with a GnRH analogue— (a) in England and Wales and Scotland, before 3rd June 2024; or (b) in Northern Ireland, before 27th August 2024. (6) For the purposes of paragraph (5), a person is treated as having started a course of treatment with a GnRH analogue if— (a) in England and Wales and Scotland, in the six month period before 3rd June 2024, that person was issued with a NHS prescription or a private prescription for a GnRH analogue, whether or not the prescription has been dispensed or the prescribed GnRH analogue has been taken by that person before 3rd June 2024 or since; or (b) in Northern Ireland, in the six month period before 27th August 2024, that person was issued with a NHS prescription or a private prescription for a GnRH analogue, whether or not the prescription has been dispensed or the prescribed GnRH analogue has been taken by that person before 27th August 2024 or since.
One line that says what changes, such as "Halve the dog tax".
Who it helps, what it costs, what it fixes. It is what persuades people to support it.
How this law is officially changed
Solon does not know this law's official route yet. The proposal is recorded all the same, and the route appears here once its source is added.
A proposal here is not law. Support on Solon is evidence that people want the change; the official route says what it takes to make it law.
Sign in to file your proposal. What you have written stays on this page.
Sign in to file itThink it through
Ask what your change would do, who would gain and who would bear a cost, and where something like it is already law. The assistant reads your draft as it stands, cites the law and the studies it finds, and takes no side. What you file stays yours.